FDA
approval
· 2015-08-17
FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Teva), a fixed-dose combination product. The action pertains to supplemental …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)